George Siber bibliography

This is a list of the works of George Siber.

Bibliography

Original articles

  1. Sherwin, A.L.; Siber, G.R.; Elhilali, M.M. (August 1967). "Fluorescence technique to demonstrate creatine phosphokinase isozymes". Clinica Chimica Acta. 17 (2): 245–249. doi:10.1016/0009-8981(67)90127-1. 
  2. Siber, G. R.; Echeverria, P.; Smith, A. L.; Paisley, J. W.; Smith, D. H. (1 December 1975). "Pharmacokinetics of Gentamicin in Children and Adults". Journal of Infectious Diseases. 132 (6): 637–651. doi:10.1093/infdis/132.6.637. 
  3. Wilson, Rickey (1 July 1979). "Toxicity of Amphotericin B in Children With Cancer". Archives of Pediatrics & Adolescent Medicine. 133 (7): 731. doi:10.1001/archpedi.1979.02130070067014. 
  4. Wilson, Christopher B. (1 May 1976). "Phycomycotic Gangrenous Cellulitis". Archives of Surgery. 111 (5): 532. doi:10.1001/archsurg.1976.01360230032005. 
  5. Siber, George R.; Alpert, Susan; Smith, Arnold L.; Lin, Juey-Shin L.; McCormack, William M. (April 1977). "Neonatal central nervous system infection due to Mycoplasma hominis". The Journal of Pediatrics. 90 (4): 625–627. doi:10.1016/S0022-3476(77)80385-5. 
  6. Weitzman, Sigmund A.; Aisenberg, Alan C.; Siber, George R.; Smith, David H. (4 August 1977). "Impaired Humoral Immunity in Treated Hodgkin's Disease". New England Journal of Medicine. 297 (5): 245–248. doi:10.1056/NEJM197708042970504. 
  7. Ward, Joel I.; Siber, George R.; Scheifele, David W.; Smith, David H. (July 1978). "Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis". The Journal of Pediatrics. 93 (1): 37–42. doi:10.1016/S0022-3476(78)80596-4. 
  8. Siber, George R.; Weitzman, Sigmund A.; Aisenberg, Alan C.; Weinstein, Howard J.; Schiffman, Gerald (31 August 1978). "Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease". New England Journal of Medicine. 299 (9): 442–448. doi:10.1056/NEJM197808312990903. 
  9. Siber, GR; Skapriwsky, P (Apr 1978). "Counterimmunoelectrophoresis for detection of microbial antigens: increased sensitivity with dextran-containing gels.". Journal of clinical microbiology. 7 (4): 392–3. PMID 357445. 
  10. Siber, George R.; Smith, Arnold L. (January 1979). "Predictability of peak serum gentamicin concentration with dosage based on body surface area". The Journal of Pediatrics. 94 (1): 135–138. doi:10.1016/S0022-3476(79)80379-0. 
  11. Duchowny, Michael; Caplan, Louis; Siber, George (May 1979). "Cytomegalovirus infection of the adult nervous system". Annals of Neurology. 5 (5): 458–461. doi:10.1002/ana.410050510. 
  12. Scheifele, DW; Daum, RS; Syriopoulou, VP; Siber, GR; Smith, AL (Dec 1979). "Comparison of two antigen detection techniques in a primate model of Haemophilus influenzae type b infection.". Infection and immunity. 26 (3): 827–31. PMID 118934. <
  13. Siber, George R.; Schur, Peter H.; Aisenberg, Alan C.; Weitzman, Sigmund A.; Schiffman, Gerald (24 July 1980). "Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide Antigens". New England Journal of Medicine. 303 (4): 178–182. doi:10.1056/NEJM198007243030402. 
  14. Siber, George R. (1 July 1980). "Bacteremias due to Haemophilus influenzae and Streptococcus pneumoniae". American Journal of Diseases of Children. 134 (7): 668. doi:10.1001/archpedi.1980.02130190036009. 
  15. Siber, GR; Ransil, BJ; Schiffman, G (May 1980). "Graphical method for evaluating antibody response to vaccines.". Infection and immunity. 28 (2): 641–4. PMID 7399682. 
  16. Siber, GR; Mayer, RJ; Levin, MJ (Oct 1980). "Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma.". Cancer Research. 40 (10): 3430–6. PMID 7438030. 
  17. Lesko, LJ; Marion, A; Ericson, J; Siber, GR (Jul 1981). "Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids.". American journal of hospital pharmacy. 38 (7): 1004–6. PMID 7258196. 
  18. Siber, GR; Weitzman, SA; Aisenberg, AC (Mar–Apr 1981). "Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.". Reviews of infectious diseases. 3 Suppl: S144–59. doi:10.1093/clinids/3.supplement_1.s144. PMID 7280445. 
  19. Scheifele, DW; Ward, JI; Siber, GR (Dec 1981). "Advantage of latex agglutination over countercurrent immunoelectrophoresis in the detection of Haemophilus influenzae type b antigen in serum.". Pediatrics. 68 (6): 888–91. PMID 6976554. 
  20. Lew, MA; Siber, GR; Donahue, DM; Maiorca, F (Jan 1982). "Enhanced detection with an enzyme-linked immunosorbent assay of candida mannan in antibody-containing serum after heat extraction.". The Journal of Infectious Diseases. 145 (1): 45–56. doi:10.1093/infdis/145.1.45. PMID 7033399. 
  21. Daum, RS; Siber, GR; Kamon, JS; Russell, RR (Apr 1982). "Evaluation of a commercial latex particle agglutination test for rapid diagnosis of Haemophilus influenzae type b infection.". Pediatrics. 69 (4): 466–71. PMID 6978478. 
  22. Siber, GR; Ambrosino, DM; Gorgone, BC (May 1982). "Blood-group-A-like substance in a preparation of pneumococcal vaccine.". Annals of Internal Medicine. 96 (5): 580–6. doi:10.7326/0003-4819-96-5-580. PMID 7073150. 
  23. Romagnoli, MF; Flynn, K; Siber, GR; Goldmann, DA (Jul 1982). "Moxalactam pharmacokinetics in children.". Antimicrobial Agents and Chemotherapy. 22 (1): 47–50. doi:10.1128/aac.22.1.47. PMID 6214997. 
  24. Siber, GR; Ransil, BJ (1983). "Methods for the analysis of antibody responses to vaccines or other immune stimuli.". Methods in enzymology. 93: 60–78. doi:10.1016/s0076-6879(83)93034-3. PMID 6865786. 
  25. Ambrosino, D; Schreiber, JR; Daum, RS; Siber, GR (Feb 1983). "Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.". Infection and immunity. 39 (2): 709–14. PMID 6601060. 
  26. Weber, A; Opheim, KE; Siber, GR; Ericson, JF; Smith, AL (Dec 9, 1983). "High-performance liquid chromatographic quantitation of trimethoprim, sulfamethoxazole, and N4-acetylsulfamethoxazole in body fluids.". Journal of Chromatography. 278 (2): 337–45. doi:10.1016/s0378-4347(00)84793-3. PMID 6668314. 
  27. Russell, R; Mather, F; Siber, G; Rosenberg, G; Daum, R (Jan 1984). "Value of antigen quantitation in Haemophilus influenzae type b meningitis.". The Journal of Pediatrics. 104 (1): 23–8. doi:10.1016/s0022-3476(84)80583-1. PMID 6690672. 
  28. Siber, GR; Ambrosino, DM; McIver, J; Ervin, TJ; Schiffman, G; Sallan, S; Grady, GF (Jul 1984). "Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.". Infection and immunity. 45 (1): 248–54. PMID 6429048. 
  29. Schreiber, JR; Barrus, VA; Siber, GR (Jan 1985). "Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b.". Infection and immunity. 47 (1): 142–8. PMID 3871195. 
  30. Goorin, AM; Hershey, BJ; Levin, MJ; Siber, GR; Gelber, RD; Flynn, K; Lew, M; Beckett, K; Blanding, P; Sallan, SE (May–Jun 1985). "Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.". Pediatric infectious disease. 4 (3): 265–9. doi:10.1097/00006454-198505000-00012. PMID 3889875. 
  31. Novitsky, TJ; Roslansky, PF; Siber, GR; Warren, HS (Feb 1985). "Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate.". Journal of clinical microbiology. 21 (2): 211–6. PMID 3972988. 
  32. Ambrosino, DM; Schiffman, G; Gotschlich, EC; Schur, PH; Rosenberg, GA; DeLange, GG; van Loghem, E; Siber, GR (Jun 1985). "Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.". The Journal of Clinical Investigation. 75 (6): 1935–42. doi:10.1172/jci111909. PMID 3924957. 
  33. Siber, GR; Kania, SA; Warren, HS (Nov 1985). "Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.". The Journal of Infectious Diseases. 152 (5): 954–64. doi:10.1093/infdis/152.5.954. PMID 2413146. 
  34. Warren, H S; Kania, S A; Siber, G R (1 July 1985). "Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide.". Antimicrobial Agents and Chemotherapy. 28 (1): 107–112. doi:10.1128/AAC.28.1.107. 
  35. Warren, HS; Novitsky, TJ; Ketchum, PA; Roslansky, PF; Kania, S; Siber, GR (Oct 1985). "Neutralization of bacterial lipopolysaccharides by human plasma.". Journal of clinical microbiology. 22 (4): 590–5. PMID 3908471. 
  36. Umetsu, DT; Ambrosino, DM; Quinti, I; Siber, GR; Geha, RS (Nov 14, 1985). "Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency.". The New England Journal of Medicine. 313 (20): 1247–51. doi:10.1056/nejm198511143132002. PMID 3877240. 
  37. Ambrosino, DM; Glode, MP; Williams, CL; Siber, GR (Jun 1985). "Antibody response of infants to Haemophilus influenzae type b capsular polysaccharide combined with Bordetella pertussis.". The Journal of Infectious Diseases. 151 (6): 1174. doi:10.1093/infdis/151.6.1174. PMID 2860187. 
  38. Ambrosino, DM; Landesman, SH; Gorham, CC; Siber, GR (Jan 1986). "Passive immunization against disease due to Haemophilus influenzae type b: concentrations of antibody to capsular polysaccharide in high-risk children.". The Journal of Infectious Diseases. 153 (1): 1–7. doi:10.1093/infdis/153.1.1. PMID 3484503. 
  39. Schreiber, JR; Barrus, V; Cates, KL; Siber, GR (Jan 1986). "Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.". The Journal of Infectious Diseases. 153 (1): 8–16. doi:10.1093/infdis/153.1.8. PMID 3484506. 
  40. Siber, GR; Gorham, C; Martin, P; Corkery, JC; Schiffman, G (Apr 1986). "Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.". Annals of Internal Medicine. 104 (4): 467–75. doi:10.7326/0003-4819-104-4-467. PMID 3082268. 
  41. Ambrosino, D M; Barrus, V A; DeLange, G G; Siber, G R (1 August 1986). "Correlation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in Caucasian adults.". Journal of Clinical Investigation. 78 (2): 361–365. doi:10.1172/JCI112585. 
  42. Warren, HS; Knights, CV; Siber, GR (Nov 1986). "Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum.". The Journal of Infectious Diseases. 154 (5): 784–91. doi:10.1093/infdis/154.5.784. PMID 3095436. 
  43. Ambrosino, DM; Siber, GR (Nov 1986). "Simultaneous administration of vaccines for Haemophilus influenzae type b, pneumococci, and meningococci.". The Journal of Infectious Diseases. 154 (5): 893–6. doi:10.1093/infdis/154.5.893. PMID 3490522. 
  44. Anderson, AB; Ambrosino, DM; Siber, GR (Jun 1987). "Haemophilus influenzae type b unsuspected bacteremia.". Pediatric emergency care. 3 (2): 82–5. doi:10.1097/00006565-198706000-00005. PMID 3497386. 
  45. Ambrosino, DM; Siber, GR; Chilmonczyk, BA; Jernberg, JB; Finberg, RW (Mar 26, 1987). "An immunodeficiency characterized by impaired antibody responses to polysaccharides.". The New England Journal of Medicine. 316 (13): 790–3. doi:10.1056/nejm198703263161306. PMID 3493431. 
  46. Warren, HS; Novitsky, TJ; Martin, P; Roslansky, PF; Siber, GR (1987). "Endotoxin neutralizing capacity of sera from different patient populations assessed by the Limulus lysate test.". Progress in clinical and biological research. 231: 341–8. PMID 3295888. 
  47. Warren, HS; Novitsky, TJ; Bucklin, A; Kania, SA; Siber, GR (Jul 1987). "Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.". Infection and immunity. 55 (7): 1668–73. PMID 3298063. 
  48. Santosham, M; Reid, R; Ambrosino, DM; Wolff, MC; Almeido-Hill, J; Priehs, C; Aspery, KM; Garrett, S; Croll, L; Foster, S (Oct 8, 1987). "Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.". The New England Journal of Medicine. 317 (15): 923–9. doi:10.1056/NEJM198710083171503. PMID 2442610. 
  49. Schreiber, JR; Basker, CJ; Siber, GR (Nov 1987). "Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b.". Infection and immunity. 55 (11): 2830–3. PMID 3499398. 
  50. Ambrosino, DM; Umetsu, DT; Siber, GR; Howie, G; Goularte, TA; Michaels, R; Martin, P; Schur, PH; Noyes, J; Schiffman, G (Jun 1988). "Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels.". The Journal of allergy and clinical immunology. 81 (6): 1175–9. doi:10.1016/0091-6749(88)90887-1. PMID 3259962. 
  51. Shurin, PA; Giebink, GS; Wegman, DL; Ambrosino, D; Rholl, J; Overman, M; Bauer, T; Siber, GR (Apr 1988). "Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin.". Journal of clinical microbiology. 26 (4): 755–9. PMID 3366870. 
  52. Ambrosino, DM; Morell, A; Vassalli, G; de Lange, GG; Skvaril, F; Siber, GR (1988). "Correlations of G2m(n) and Km(1) allotypes with subclass- and light-chain-specific antibody.". Monographs in allergy. 23: 244–55. PMID 3133558. 
  53. Smith, AL; Daum, RS; Siber, GR; Scheifele, DW; Syriopoulou, VP (Jul 1988). "Gentamicin penetration into cerebrospinal fluid in experimental Haemophilus influenzae meningitis.". Antimicrobial Agents and Chemotherapy. 32 (7): 1034–9. doi:10.1128/aac.32.7.1034. PMID 3190192. 
  54. Letson, GW; Santosham, M; Reid, R; Priehs, C; Burns, B; Jahnke, A; Gahagan, S; Nienstadt, L; Johnson, C; Smith, D (Nov 1988). "Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b.". The Pediatric Infectious Disease Journal. 7 (11): 747–52. doi:10.1097/00006454-198811000-00001. PMID 3266005. 
  55. Sood, SK; Schreiber, JR; Siber, GR; Daum, RS (Nov 1988). "Postvaccination susceptibility to invasive Haemophilus influenzae type b disease in infant rats.". The Journal of Pediatrics. 113 (5): 814–9. doi:10.1016/s0022-3476(88)80006-4. PMID 3263486. 
  56. SIBER, GEORGE R.; PRIEHS, CLAUDETTE; MADORE, DACE V. (January 1989). "Standardization of antibody assays for measuring the response to pneumococcal infection and immunization". The Pediatric Infectious Disease Journal. 8 (Supplement): S91. doi:10.1097/00006454-198901001-00030. 
  57. Morell, A; Vassalli, G; DeLange, GG; Skvaril, F; Ambrosino, DM; Siber, GR (Apr 1, 1989). "Ig allotype-linked regulation of class and subclass composition of natural antibodies to group A streptococcal carbohydrate.". Journal of immunology (Baltimore, Md. : 1950). 142 (7): 2495–500. PMID 2647851. 
  58. Santosham, M; Reid, R; Letson, GW; Wolff, MC; Siber, G (Apr 1990). "Passive immunization for infection with Haemophilus influenzae type b.". Pediatrics. 85 (4 Pt 2): 662–6. PMID 2179857. 
  59. Ambrosino, DM; Greif, W; Thompson, C; Siber, GR (May 1990). "Kappa and lambda light chain composition of antibody to the capsular polysaccharide of Haemophilus influenzae type b.". The Journal of Infectious Diseases. 161 (5): 922–5. doi:10.1093/infdis/161.5.922. PMID 2109020. 
  60. Siber, GR; Santosham, M; Reid, GR; Thompson, C; Almeido-Hill, J; Morell, A; deLange, G; Ketcham, JK; Callahan, EH (Nov 15, 1990). "Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.". The New England Journal of Medicine. 323 (20): 1387–92. doi:10.1056/nejm199011153232005. PMID 2233905. 
  61. Meissner, C; Reimer, CB; Black, C; Broome, C; Rabson, A; Siber, GR; Delaney, N; Connors, M; Ambrosino, DM (Nov 1990). "Interpretation of IgG subclass values: a comparison of two assays.". The Journal of Pediatrics. 117 (5): 726–31. doi:10.1016/s0022-3476(05)83328-1. PMID 2121946. 
  62. Licari, P; Siber, GR; Swartz, R (Sep 1991). "Production of cell mass and pertussis toxin by Bordetella pertussis.". Journal of biotechnology. 20 (2): 117–29. doi:10.1016/0168-1656(91)90221-g. PMID 1367364. 
  63. Siber, GR; Thakrar, N; Yancey, BA; Herzog, L; Todd, C; Cohen, N; Sekura, RD; Lowe, CU (Oct 1991). "Safety and immunogenicity of hydrogen peroxide-inactivated pertussis toxoid in 18-month-old children.". Vaccine. 9 (10): 735–40. doi:10.1016/0264-410x(91)90289-i. PMID 1759491. 
  64. Baldwin, G; Alpert, G; Caputo, GL; Baskin, M; Parsonnet, J; Gillis, ZA; Thompson, C; Siber, GR; Fleisher, GR (Sep 1991). "Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins.". The Journal of Infectious Diseases. 164 (3): 542–9. doi:10.1093/infdis/164.3.542. PMID 1908001. 
  65. Daum, RS; Siber, GR; Ballanco, GA; Sood, SK (Dec 1991). "Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine.". The Journal of Infectious Diseases. 164 (6): 1154–9. doi:10.1093/infdis/164.6.1154. PMID 1955715. 
  66. Alpert, G; Baldwin, G; Thompson, C; Wainwright, N; Novitsky, TJ; Gillis, Z; Parsonnet, J; Fleisher, GR; Siber, GR (Mar 1992). "Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock.". The Journal of Infectious Diseases. 165 (3): 494–500. doi:10.1093/infdis/165.3.494. PMID 1538154. 
  67. Siber, GR; Leszcynski, J; Pena-Cruz, V; Ferren-Gardner, C; Anderson, R; Hemming, VG; Walsh, EE; Burns, J; McIntosh, K; Gonin, R (Mar 1992). "Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay.". The Journal of Infectious Diseases. 165 (3): 456–63. doi:10.1093/infdis/165.3.456. PMID 1538152. 
  68. Rose, RM; Rey-Martinez, J; Croteau, C; Silvestri, RC; Haley, K; DePamphilis, J; Siber, GR (Apr 1992). "Failure of recombinant interleukin-2 to augment the primary humoral response to a recombinant hepatitis B vaccine in healthy adults.". The Journal of Infectious Diseases. 165 (4): 775–7. doi:10.1093/infdis/165.4.775b. PMID 1532407. 
  69. Samore, MH; Siber, GR (May 1992). "Effect of pertussis toxin on susceptibility of infant rats to Haemophilus influenzae type b.". The Journal of Infectious Diseases. 165 (5): 945–8. doi:10.1093/infdis/165.5.945. PMID 1533239. 
  70. Gheesling, LL; Carlone, GM; Pais, LB; Holder, PF; Maslanka, SE; Plikaytis, BD; Achtman, M; Densen, P; Frasch, CE; Käyhty, H (Jun 1994). "Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.". Journal of clinical microbiology. 32 (6): 1475–82. PMID 8077392. 
  71. Caputo, GL; Baldwin, G; Alpert, G; Parsonnet, J; Gillis, ZA; Siber, G; Fleisher, G (Feb 1992). "Effect of meningococcal endotoxin in a rabbit model of shock.". Circulatory shock. 36 (2): 104–12. PMID 1582001. 
  72. Santosham, M; Rivin, B; Wolff, M; Reid, R; Newcomer, W; Letson, GW; Almeido-Hill, J; Thompson, C; Siber, GR (Jun 1992). "Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.". The Journal of Infectious Diseases. 165 Suppl 1: S144–51. doi:10.1093/infdis/165-supplement_1-s144. PMID 1588150. 
  73. Quiambao, BP; Nohynek, H; Käyhty, H; Ollgren, J; Gozum, L; Gepanayao, CP; Soriano, V; Mäkela, PH (Jul 28, 2003). "Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines.". Vaccine. 21 (24): 3451–4. doi:10.1016/s0264-410x(03)00349-9. PMID 12850358. 
  74. Siber, GR; Thompson, C; Reid, GR; Almeido-Hill, J; Zacher, B; Wolff, M; Santosham, M (Jun 1992). "Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.". The Journal of Infectious Diseases. 165 Suppl 1: S129–33. doi:10.1093/infdis/165-supplement_1-s129. PMID 1588146. 
  75. Siber, GR (Jul 23, 1992). "Immune globulin to prevent nosocomial infections.". The New England Journal of Medicine. 327 (4): 269–71. doi:10.1056/nejm199207233270409. PMID 1614468. 
  76. Saladino, R; Baldwin, G; Alpert, G; Parsonnet, J; Gillis, Z; Thompson, C; Siber, G; Fleisher, G (Jun 1992). "Effect of a human immunoglobulin preparation for intravenous use in a rabbit model of meningococcal endotoxin-induced shock.". Critical Care Medicine. 20 (6): 816–22. doi:10.1097/00003246-199206000-00020. PMID 1597037. 
  77. Saladino, Richard; Erikson, Mark; Levy, Nancy; Bachman, David; Silber, George R; Fleisher, Gary R (December 1992). "Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children". Annals of Emergency Medicine. 21 (12): 1413–1417. doi:10.1016/S0196-0644(05)80051-4. PMID 1443833. 
  78. Siber, GR; Snydman, DR (1992). "Use of immune globulins in the prevention and treatment of infections.". Current clinical topics in infectious diseases. 12: 208–56. PMID 1642800. 
  79. Siber, GR; Werner, BG; Halsey, NA; Reid, R; Almeido-Hill, J; Garrett, SC; Thompson, C; Santosham, M (Feb 1993). "Interference of immune globulin with measles and rubella immunization.". The Journal of Pediatrics. 122 (2): 204–11. doi:10.1016/s0022-3476(06)80114-9. PMID 8429432. 
  80. Chung, GH; Scott, MG; Kim, KH; Kearney, J; Siber, GR; Ambrosino, DM; Nahm, MH (Oct 15, 1993). "Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. V. In vivo expression of individual antibody clones is dependent on Ig CH haplotypes and the categories of antigen.". Journal of immunology (Baltimore, Md. : 1950). 151 (8): 4352–61. PMID 8409407. 
  81. Leszczynski, J; Gupta, CK; Siber, GR (Sep 1993). "The use of intravenous gamma globulin for CMV prophylaxis.". Transplantation. 56 (3): 765. doi:10.1097/00007890-199309000-00043. PMID 8212176. 
  82. Reid, R; Santosham, M; Croll, J; Thompson, C; Newcomer, W; Siber, GR (Oct 1993). "Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine.". The Pediatric Infectious Disease Journal. 12 (10): 812–5. doi:10.1097/00006454-199310000-00003. PMID 8284116. 
  83. Alonso, MJ; Cohen, S; Park, TG; Gupta, RK; Siber, GR; Langer, R (Jul 1993). "Determinants of release rate of tetanus vaccine from polyester microspheres.". Pharmaceutical Research. 10 (7): 945–53. doi:10.1023/A:1018942118148. ISSN 1573-904X. PMID 8378256. 
  84. Jaganathan, K.S.; Rao, Y.U.B.; Singh, Paramjit; Prabakaran, D.; Gupta, Swati; Jain, Anubhav; Vyas, Suresh P. (April 2005). "Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(d,l-lactic-co-glycolic acid) versus chitosan microspheres". International Journal of Pharmaceutics. 294 (1-2): 23–32. doi:10.1016/j.ijpharm.2004.12.026. 
  85. Groothuis, JR; Simoes, EA; Levin, MJ; Hall, CB; Long, CE; Rodriguez, WJ; Arrobio, J; Meissner, HC; Fulton, DR; Welliver, RC (Nov 18, 1993). "Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.". The New England Journal of Medicine. 329 (21): 1524–30. doi:10.1056/NEJM199311183292102. PMID 8413475. 
  86. Hoess, A; Watson, S; Siber, GR; Liddington, R (Sep 1993). "Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution.". The EMBO Journal. 12 (9): 3351–6. PMID 8253062. 
  87. Shurin, PA; Rehmus, JM; Johnson, CE; Marchant, CD; Carlin, SA; Super, DM; Van Hare, GF; Jones, PK; Ambrosino, DM; Siber, GR (Nov 1993). "Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children.". The Journal of Pediatrics. 123 (5): 801–10. doi:10.1016/S0022-3476(05)80865-0. PMID 8229496. 
  88. Marchant, CD; Loughlin, AM; Lett, SM; Todd, CW; Wetterlow, LH; Bicchieri, R; Higham, S; Etkind, P; Silva, E; Siber, GR (Jun 1994). "Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness.". The Journal of Infectious Diseases. 169 (6): 1297–305. doi:10.1093/infdis/169.6.1297. ISSN 0022-1899. PMID 8195607. 
  89. Alonso, MJ; Gupta, RK; Min, C; Siber, GR; Langer, R (Mar 1994). "Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.". Vaccine. 12 (4): 299–306. doi:10.1016/0264-410X(94)90092-2. ISSN 0264-410X. PMID 8178550. 
  90. Guinan, EC; Molrine, DC; Antin, JH; Lee, MC; Weinstein, HJ; Sallan, SE; Parsons, SK; Wheeler, C; Gross, W; McGarigle, C (Mar 15, 1994). "Polysaccharide conjugate vaccine responses in bone marrow transplant patients.". Transplantation. 57 (5): 677–84. doi:10.1097/00007890-199403150-00009. ISSN 0041-1337. PMID 8140632. 
  91. Gupta, RK; Siber, GR (Mar 1994). "Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.". Biologicals : journal of the International Association of Biological Standardization. 22 (1): 53–63. doi:10.1006/biol.1994.1008. ISSN 1045-1056. PMID 8068314. 
  92. Gupta, RK; Higham, S; Gupta, CK; Rost, B; Siber, GR (Mar 1994). "Suitability of the Vero cell method for titration of diphtheria antitoxin in the United States potency test for diphtheria toxoid.". Biologicals : journal of the International Association of Biological Standardization. 22 (1): 65–72. doi:10.1006/biol.1994.1009. ISSN 1045-1056. PMID 8068315. 
  93. Gupta, RK; Siber, GR (Sep 1994). "Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay.". Biologicals : journal of the International Association of Biological Standardization. 22 (3): 215–9. doi:10.1006/biol.1994.1031. ISSN 1045-1056. PMID 7811454. 
  94. Siber, GR; Leombruno, D; Leszczynski, J; McIver, J; Bodkin, D; Gonin, R; Thompson, CM; Walsh, EE; Piedra, PA; Hemming, VG (Jun 1994). "Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin.". The Journal of Infectious Diseases. 169 (6): 1368–73. doi:10.1093/infdis/169.6.1368. ISSN 0022-1899. PMID 8195619. 
  95. Saladino, R; Garcia, C; Thompson, C; Hammer, B; Parsonnet, J; Novitsky, T; Siber, G; Fleisher, G (Feb 1994). "Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.". Circulatory shock. 42 (2): 104–10. ISSN 0092-6213. PMID 8013061. 
  96. Singleton, RJ; Davidson, NM; Desmet, IJ; Berner, JE; Wainwright, RB; Bulkow, LR; Lilly, CM; Siber, GR (May 1994). "Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization.". The Pediatric Infectious Disease Journal. 13 (5): 362–7. doi:10.1097/00006454-199405000-00006. ISSN 0891-3668. PMID 8072817. 
  97. Mulholland, EK; Hoestermann, A; Suara, RO; Adegbola, RA; Siber, G; Thompson, C; Greenwood, BM (Mar 26, 1994). "Haemophilus influenzae type b meningitis after three doses of vaccine.". Lancet. 343 (8900): 794. doi:10.1016/s0140-6736(94)91870-8. PMID 7907751. 
  98. Lynn, F; Burnette, WN; Siber, GR; Arciniega, JL (Nov 1994). "Human antibody response to the B oligomer of pertussis toxin.". Clinical and diagnostic laboratory immunology. 1 (6): 626–32. PMID 8556512. 
  99. Siber, GR (Sep 2, 1994). "Pneumococcal disease: prospects for a new generation of vaccines.". Science. 265 (5177): 1385–7. doi:10.1126/science.8073278. PMID 8073278. 
  100. Gheesling, LL; Carlone, GM; Pais, LB; Holder, PF; Maslanka, SE; Plikaytis, BD; Achtman, M; Densen, P; Frasch, CE; Käyhty, H (Jun 1994). "Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.". Journal of clinical microbiology. 32 (6): 1475–82. PMID 8077392. 
  101. Hemming, VG; Prince, GA; Groothuis, JR; Siber, GR (Jan 1995). "Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.". Clinical Microbiology Reviews. 8 (1): 22–33. PMID 7704893. 
  102. Siber, GR; Anderson, R; Habafy, M; Gupta, RK (Apr 1995). "Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines.". Vaccine. 13 (6): 525–31. doi:10.1016/0264-410x(94)00042-l. PMID 7483772. 
  103. Englund, JA; Glezen, WP; Turner, C; Harvey, J; Thompson, C; Siber, GR (Jan 1995). "Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.". The Journal of Infectious Diseases. 171 (1): 99–105. doi:10.1093/infdis/171.1.99. PMID 7798688. 
  104. Garcia, C; Saladino, R; Thompson, C; Hammer, B; Parsonnet, J; Wainwright, N; Novitsky, T; Fleisher, GR; Siber, G (Aug 1994). "Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.". Critical Care Medicine. 22 (8): 1211–8. doi:10.1097/00003246-199408000-00003. PMID 8045139. 
  105. Nelson, Douglas; Kuppermann, Nathan; Fleisher, Gary R.; Hammer, Brian K.; Thompson, Claudette M.; Garcia, Carmen T.; Novitsky, Thomas J.; Parsonnet, Jeffrey; Onderdonk, Andrew; Siber, George R.; Saladino, Richard A. (January 1995). "Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats". Critical Care Medicine. 23 (1): 92–98. doi:10.1097/00003246-199501000-00017. PMID 8001394. 
  106. Gupta, RK; Siber, GR (Apr 12, 1995). "Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay.". Journal of immunological methods. 181 (1): 75–81. doi:10.1016/0022-1759(94)00331-P. PMID 7730666. 
  107. Gupta, RK; Anderson, R; Cecchini, D; Rost, B; Griffin P, Jr; Benscoter, K; Xu, J; Montanez-Ortiz, L; Siber, GR (1996). "Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.". Developments in biological standardization. 86: 283–96. PMID 8785957. 
  108. Groothuis, J. R.; Simoes, E. A.; Lehr, M. V.; Kramer, A. A.; Hemming, V. G.; Rodriguez, W. J.; Arrobio, J.; Welliver, R. C.; Siber, G. R. (1 March 1995). "Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin". Antimicrobial Agents and Chemotherapy. 39 (3): 668–671. doi:10.1128/AAC.39.3.668. 
  109. Gupta, RK; Siber, GR (Oct 1995). "Adjuvants for human vaccines--current status, problems and future prospects.". Vaccine. 13 (14): 1263–76. doi:10.1016/0264-410x(95)00011-o. PMID 8585280. 
  110. Saladino, RA; Stack, AM; Thompson, C; Sattler, F; Novitsky, TJ; Siber, GR; Fleisher, GR (Jul 1996). "High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.". Critical Care Medicine. 24 (7): 1203–7. doi:10.1097/00003246-199607000-00023. PMID 8674336. 
  111. Frohlich, BT; De Bernardez Clark, ER; Siber, GR; Swartz, RW (May 1, 1995). "Improved pertussis toxin production by Bordetella pertussis through adjusting the growth medium's ionic composition.". Journal of biotechnology. 39 (3): 205–19. doi:10.1016/0168-1656(95)00013-g. PMID 7766402. 
  112. Mulholland, K; Suara, RO; Siber, G; Roberton, D; Jaffar, S; N'Jie, J; Baden, L; Thompson, C; Anwaruddin, R; Dinan, L; Glezen, WP; Francis, N; Fritzell, B; Greenwood, BM (Apr 17, 1996). "Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.". JAMA: The Journal of the American Medical Association. 275 (15): 1182–8. doi:10.1001/jama.1996.03530390048033. PMID 8609686. 
  113. Gupta, RK; Varanelli, CL; Griffin, P; Wallach, DF; Siber, GR (Feb 1996). "Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.". Vaccine. 14 (3): 219–25. doi:10.1016/0264-410X(95)00182-Z. PMID 8920703. 
  114. Fröhlich, Bert T; d'Alarcao, Marc; Feldberg, Ross S; Nicholson, Mary L; Siber, George R; Swartz, Randall W (February 1996). "Formation and cell-medium partitioning of autoinhibitory free fatty acids and cyclodextrin's effect in the cultivation of Bordetella pertussis". Journal of Biotechnology. 45 (2): 137–148. doi:10.1016/0168-1656(95)00155-7. PMID 9147447. 
  115. Samore, MH; Siber, GR (Mar 1996). "Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone.". Vaccine. 14 (4): 290–7. doi:10.1016/0264-410X(95)00201-B. ISSN 0264-410X. PMID 8744555. 
  116. De Vincenzo, JP; Leombruno, D; Soiffer, RJ; Siber, GR (Jun 1996). "Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation.". Bone marrow transplantation. 17 (6): 1051–6. PMID 8807113. 
  117. Schwendeman, S. P.; Costantino, H. R.; Gupta, R. K.; Siber, G. R.; Klibanov, A. M.; Langer, R. (21 November 1995). "Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.". Proceedings of the National Academy of Sciences. 92 (24): 11234–11238. doi:10.1073/pnas.92.24.11234. 
  118. Groothuis, JR; Simoes, EA; Hemming, VG (Apr 1995). "Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.". Pediatrics. 95 (4): 463–7. PMID 7700741. 
  119. Weiner, DL; Kuppermann, N; Saladino, RA; Thompson, CM; Novitsky, TJ; Siber, GR; Fleisher, GR (Sep 1996). "Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.". Critical Care Medicine. 24 (9): 1514–7. doi:10.1097/00003246-199609000-00014. PMID 8797624. 
  120. Chung, GH; Kim, KH; Daum, RS; Insel, RA; Siber, GR; Sood, S; Gupta, RK; Marchant, C; Nahm, MH (Nov 1995). "The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants.". Infection and immunity. 63 (11): 4219–23. PMID 7591050. 
  121. Crowe, J; Siber, GR (June 1995). "Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization". Vaccine. 13 (9): 847–855. doi:10.1016/0264-410X(94)00074-W. 
  122. Gupta, Rajesh K.; Siber, George R. (March 1995). "Need for a reference preparation of pertussis antitoxin for Chinese hamster ovary cell assay". Biologicals. 23 (1): 71–73. doi:10.1016/1045-1056(95)90015-2. PMID 7619440. 
  123. Shahid, NS; Steinhoff, MC; Hoque, SS; Begum, T; Thompson, C; Siber, GR (Nov 11, 1995). "Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.". Lancet. 346 (8985): 1252–7. doi:10.1016/s0140-6736(95)91861-2. PMID 7475716. 
  124. Gupta, RK; Siber, GR (Aug 1995). "Reappraisal of existing methods for potency testing of vaccines against tetanus and diphtheria.". Vaccine. 13 (11): 965–6. doi:10.1016/0264-410x(95)00027-x. PMID 8525688. 
  125. Gupta, RK; Siber, GR (1996). "Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.". Developments in biological standardization. 86: 207–15. PMID 8785950. 
  126. Frohlich, BT; d'Alarcao, M; Feldberg, RS; Nicholson, ML; Siber, GR; Swartz, RW (Feb 28, 1996). "Formation and cell-medium partitioning of autoinhibitory free fatty acids and cyclodextrin's effect in the cultivation of Bordetella pertussis.". Journal of biotechnology. 45 (2): 137–48. doi:10.1016/0168-1656(95)00155-7. PMID 9147447. 
  127. Madore, DV; Anderson, P; Baxter, BD; Carlone, GM; Edwards, KM; Hamilton, RG; Holder, P; Käyhty, H; Phipps, DC; Peeters, CC; Schneerson, R; Siber, GR; Ward, JI; Frasch, CE (Jan 1996). "Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.". Clinical and diagnostic laboratory immunology. 3 (1): 84–8. PMID 8770509. 
  128. Nahm, MH; Siber, GR; Olander, JV (Jan 1996). "A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides.". The Journal of Infectious Diseases. 173 (1): 113–8. doi:10.1093/infdis/173.1.113. PMID 8537647. 
  129. Schwendeman, SP; Costantino, HR; Gupta, RK; Tobio, M; Chang, AC; Alonso, MJ; Siber, GR; Langer, R (1996). "Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.". Developments in biological standardization. 87: 293–306. PMID 8854030. 
  130. Gupta, RK; Griffin P, Jr; Xu, J; Rivera, R; Thompson, C; Siber, GR (Jun 1996). "Diphtheria antitoxin levels in US blood and plasma donors.". The Journal of Infectious Diseases. 173 (6): 1493–7. doi:10.1093/infdis/173.6.1493. PMID 8648228. 
  131. Sanchez, A; Gupta, RK; Alonso, MJ; Siber, GR; Langer, R (Jun 1996). "Pulsed controlled-released system for potential use in vaccine delivery.". Journal of pharmaceutical sciences. 85 (6): 547–52. doi:10.1021/js960069y. PMID 8773947. 
  132. Brubaker, JO; Thompson, CM; Morrison, LA; Knipe, DM; Siber, GR; Finberg, RW (Aug 15, 1996). "Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.". Journal of immunology (Baltimore, Md. : 1950). 157 (4): 1598–604. PMID 8759744. 
  133. Park, MK; Englund, JA; Glezen, WP; Siber, GR; Nahm, MH (Sep 1996). "Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions.". Vaccine. 14 (13): 1219–22. doi:10.1016/s0264-410x(96)00029-1. PMID 8961508. 
  134. Simoes, EA; Groothuis, JR; Tristram, DA; Allessi, K; Lehr, MV; Siber, GR; Welliver, RC (Aug 1996). "Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children.". The Journal of Pediatrics. 129 (2): 214–9. doi:10.1016/s0022-3476(96)70245-7. PMID 8765618. 
  135. Gupta, RK; Chang, AC; Griffin, P; Rivera, R; Siber, GR (Oct 1996). "In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.". Vaccine. 14 (15): 1412–6. doi:10.1016/s0264-410x(96)00073-4. PMID 8994315. 
  136. Gupta, CK; Leszczynski, J; Gupta, RK; Siber, GR (Jun 1996). "IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.". Biologicals : journal of the International Association of Biological Standardization. 24 (2): 117–24. doi:10.1006/biol.1996.0015. PMID 8889058. 
  137. Siber, GR (1 January 1997). "Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis". Pediatrics. 99 (1): 93–99. doi:10.1542/peds.99.1.93. PMID 8989345. 
  138. Gupta, Rajesh K.; Chang, An-Cheng; Griffin, Paul; Rivera, Rachel; Guo, Yu-Yi; Siber, George R. (April 1997). "Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid". Vaccine. 15 (6-7): 672–678. doi:10.1016/S0264-410X(96)00233-2. 
  139. Gupta, RK; Collier, RJ; Rappuoli, R; Siber, GR (Aug–Sep 1997). "Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs.". Vaccine. 15 (12-13): 1341–3. doi:10.1016/s0264-410x(97)00034-0. PMID 9302741. 
  140. Stack, AM; Saladino, RA; Siber, GR; Thompson, C; Marra, MN; Novitsky, TJ; Fleisher, GR (Jan 1997). "A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .". Critical Care Medicine. 25 (1): 101–5. doi:10.1097/00003246-199701000-00020. PMID 8989184. 
  141. Siber, GR (1997). "Methods for estimating serological correlates of protection.". Developments in biological standardization. 89: 283–96. PMID 9272362. 
  142. Meydani, SN; Meydani, M; Blumberg, JB; Leka, LS; Siber, G; Loszewski, R; Thompson, C; Pedrosa, MC; Diamond, RD; Stollar, BD (May 7, 1997). "Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.". JAMA: The Journal of the American Medical Association. 277 (17): 1380–6. doi:10.1001/jama.277.17.1380. PMID 9134944. 
  143. Gupta, RK; Alroy, J; Alonso, MJ; Langer, R; Siber, GR (Nov 1997). "Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.". Vaccine. 15 (16): 1716–23. doi:10.1016/s0264-410x(97)00116-3. PMID 9364673. 
  144. Saladino, RA; Stack, AM; Fleisher, GR; Thompson, CM; Briles, DE; Kobzik, L; Siber, GR (Nov 1997). "Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats.". Infection and immunity. 65 (11): 4701–4. PMID 9353053. 
  145. Englund, JA; Glezen, WP; Thompson, C; Anwaruddin, R; Turner, CS; Siber, GR (Dec 1997). "Haemophilus influenzae type b-specific antibody in infants after maternal immunization.". The Pediatric Infectious Disease Journal. 16 (12): 1122–30. doi:10.1097/00006454-199712000-00005. PMID 9427456. 
  146. Guo, YY; Anderson, R; McIver, J; Gupta, RK; Siber, GR (Mar 1998). "A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine.". Biologicals : journal of the International Association of Biological Standardization. 26 (1): 33–8. doi:10.1006/biol.1997.0121. PMID 9637747. 
  147. Gupta, RK; Chang, AC; Siber, GR (1998). "Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.". Developments in biological standardization. 92: 63–78. PMID 9554260. 
  148. Payne, LG; Van Nest, G; Barchfeld, GL; Siber, GR; Gupta, RK; Jenkins, SA (1998). "PCPP as a parenteral adjuvant for diverse antigens.". Developments in biological standardization. 92: 79–87. PMID 9554261. 
  149. Gupta, RK; Griffin P, Jr; Rivera, R; Siber, GR (1998). "Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.". Developments in biological standardization. 92: 277–87. PMID 9554282. 
  150. Drabick, JJ; Bhattacharjee, AK; Hoover, DL; Siber, GE; Morales, VE; Young, LD; Brown, SL; Cross, AS (Mar 1998). "Covalent polymyxin B conjugate with human immunoglobulin G as an antiendotoxin reagent.". Antimicrobial Agents and Chemotherapy. 42 (3): 583–8. PMID 9517936. 
  151. Stack, AM; Malley, R; Thompson, CM; Kobzik, L; Siber, GR; Saladino, RA (Apr 1998). "Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats.". The Journal of Infectious Diseases. 177 (4): 986–90. doi:10.1086/515259. PMID 9534972. 
  152. Molrine, DC; Siber, GR; Samra, Y; Shevy, DS; MacDonald, K; Cieri, R; Ambrosino, DM (Feb 1999). "Normal IgG and impaired IgM responses to polysaccharide vaccines in asplenic patients.". The Journal of Infectious Diseases. 179 (2): 513–7. doi:10.1086/314582. PMID 9878041. 
  153. Bruss, JB; Malley, R; Halperin, S; Dobson, S; Dhalla, M; Mciver, J; Siber, GR (Jun 1999). "Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin.". The Pediatric Infectious Disease Journal. 18 (6): 505–11. doi:10.1097/00006454-199906000-00006. PMID 10391179. 
  154. Bruss, JB; Siber, GR (Jul 1999). "Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.". Clinical and diagnostic laboratory immunology. 6 (4): 464–70. PMID 10391844. 
  155. Shinefield, HR; Black, S; Ray, P; Chang, I; Lewis, N; Fireman, B; Hackell, J; Paradiso, PR; Siber, G; Kohberger, R; Madore, DV; Malinowski, FJ; Kimura, A; Le, C; Landaw, I; Aguilar, J; Hansen, J (Sep 1999). "Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.". The Pediatric Infectious Disease Journal. 18 (9): 757–63. doi:10.1097/00006454-199909000-00004. PMID 10493334. 
  156. Gupta, RK; Anderson, R; Cecchini, D; Rost, B; Xu, J; Gendreau, K; Saroff, DL; Marchant, C; Siber, GR (Jun 1999). "Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.". Biologicals : journal of the International Association of Biological Standardization. 27 (2): 167–76. doi:10.1006/biol.1999.0204. PMID 10600208. 
  157. Rahman, MM; Mahalanabis, D; Hossain, S; Wahed, MA; Alvarez, JO; Siber, GR; Thompson, C; Santosham, M; Fuchs, GJ (Dec 1999). "Simultaneous vitamin A administration at routine immunization contact enhances antibody response to diphtheria vaccine in infants younger than six months.". The Journal of Nutrition. 129 (12): 2192–5. PMID 10573548. 
  158. Hausdorff, WP; Bryant, J; Kloek, C; Paradiso, PR; Siber, GR (Jan 2000). "The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.". Clinical Infectious Diseases. 30 (1): 122–40. doi:10.1086/313609. PMID 10619741. 
  159. Black, S; Shinefield, H; Fireman, B; Lewis, E; Ray, P; Hansen, JR; Elvin, L; Ensor, KM; Hackell, J; Siber, G; Malinoski, F; Madore, D; Chang, I; Kohberger, R; Watson, W; Austrian, R; Edwards, K (Mar 2000). "Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.". The Pediatric Infectious Disease Journal. 19 (3): 187–95. doi:10.1097/00006454-200003000-00003. PMID 10749457. 
  160. Hausdorff, WP; Bryant, J; Paradiso, PR; Siber, GR (Jan 2000). "Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.". Clinical Infectious Diseases. 30 (1): 100–21. doi:10.1086/313608. PMID 10619740. 
  161. Eskola, J; Kilpi, T; Palmu, A; Jokinen, J; Haapakoski, J; Herva, E; Takala, A; Käyhty, H; Karma, P; Kohberger, R; Siber, G; Mäkelä, PH; Finnish Otitis Media Study Group (Feb 8, 2001). "Efficacy of a pneumococcal conjugate vaccine against acute otitis media.". The New England Journal of Medicine. 344 (6): 403–9. doi:10.1056/nejm200102083440602. PMID 11172176. 
  162. Hausdorff, WP; Siber, G; Paradiso, PR (Mar 24, 2001). "Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children.". Lancet. 357 (9260): 950–2. doi:10.1016/s0140-6736(00)04222-7. PMID 11289365. 
  163. Moulton, LH; O'Brien, KL; Kohberger, R; Chang, I; Reid, R; Weatherholtz, R; Hackell, JG; Siber, GR; Santosham, M (Aug 2001). "Design of a group-randomized Streptococcus pneumoniae vaccine trial.". Controlled clinical trials. 22 (4): 438–52. doi:10.1016/s0197-2456(01)00132-5. PMID 11514043. 
  164. Quataert, S; Martin, D; Anderson, P; Giebink, GS; Henrichsen, J; Leinonen, M; Granoff, DM; Russell, H; Siber, G; Faden, H; Barnes, D; Madore, DV (Aug 2001). "A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.". Immunological investigations. 30 (3): 191–207. doi:10.1081/imm-100105064. PMID 11570640. 
  165. Santosham, M; Englund, JA; McInnes, P; Croll, J; Thompson, CM; Croll, L; Glezen, WP; Siber, GR (Oct 2001). "Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.". The Pediatric Infectious Disease Journal. 20 (10): 931–40. doi:10.1097/00006454-200110000-00005. PMID 11642626. 
  166. Shahid, NS; Steinhoff, MC; Roy, E; Begum, T; Thompson, CM; Siber, GR (May 22, 2002). "Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation.". Vaccine. 20 (17-18): 2404–9. doi:10.1016/s0264-410x(02)00061-0. PMID 12009297. 
  167. Bruss, JB; Siber, GR (Aug 2002). "Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.". Infection and immunity. 70 (8): 4600–8. doi:10.1128/iai.70.8.4600-4608.2002. PMID 12117973. 
  168. Jódar, L; Butler, J; Carlone, G; Dagan, R; Goldblatt, D; Käyhty, H; Klugman, K; Plikaytis, B; Siber, G; Kohberger, R; Chang, I; Cherian, T (Jul 4, 2003). "Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.". Vaccine. 21 (23): 3265–72. doi:10.1016/s0264-410x(03)00230-5. PMID 12804857. 
  169. O'Brien, KL; Moulton, LH; Reid, R; Weatherholtz, R; Oski, J; Brown, L; Kumar, G; Parkinson, A; Hu, D; Hackell, J; Chang, I; Kohberger, R; Siber, G; Santosham, M (Aug 2, 2003). "Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.". Lancet. 362 (9381): 355–61. doi:10.1016/s0140-6736(03)14022-6. PMID 12907008. 
  170. Klugman, Keith P.; Madhi, Shabir A.; Huebner, Robin E.; Kohberger, Robert; Mbelle, Nontombi; Pierce, Nathaniel (2 October 2003). "A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection". New England Journal of Medicine. 349 (14): 1341–1348. doi:10.1056/NEJMoa035060. 
  171. Dagan, R; Givon-Lavi, N; Fraser, D; Lipsitch, M; Siber, GR; Kohberger, R (Aug 1, 2005). "Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.". The Journal of Infectious Diseases. 192 (3): 367–76. doi:10.1086/431679. PMID 15995949. 
  172. Moulton, L. H.; O'Brien, K. L.; Reid, R.; Weatherholtz, R.; Santosham, M.; Siber, G. R. (August 2006). "Evaluation of the Indirect Effects of a Pneumococcal Vaccine in a Community-Randomized Study". Journal of Biopharmaceutical Statistics. 16 (4): 453–462. doi:10.1080/10543400600719343. 
  173. Santosham, M; Reid, R; Chandran, A; Millar, EV; Watt, JP; Weatherholtz, R; Donaldson, C; Croll, J; Moulton, LH; Thompson, CM; Siber, GR; O'Brien, KL (Mar 22, 2007). "Contributions of Native Americans to the global control of infectious diseases.". Vaccine. 25 (13): 2366–74. doi:10.1016/j.vaccine.2006.09.002. PMID 17069936. 
  174. Siber, GR; Chang, I; Baker, S; Fernsten, P; O'Brien, KL; Santosham, M; Klugman, KP; Madhi, SA; Paradiso, P; Kohberger, R (May 10, 2007). "Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.". Vaccine. 25 (19): 3816–26. doi:10.1016/j.vaccine.2007.01.119. PMID 17368878. 
  175. O'Brien, KL; Moisi, J; Moulton, LH; Madore, D; Eick, A; Reid, R; Weatherholtz, R; Millar, E; Hu, D; Hackell, J; Kohberger, R; Siber, G; Santosham, M (Jul 1, 2007). "Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.". The Journal of Infectious Diseases. 196 (1): 104–14. doi:10.1086/518438. PMID 17538890. 
  176. Scott, DA; Komjathy, SF; Hu, BT; Baker, S; Supan, LA; Monahan, CA; Gruber, W; Siber, GR; Lockhart, SP (Aug 14, 2007). "Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults.". Vaccine. 25 (33): 6164–6. doi:10.1016/j.vaccine.2007.06.004. PMID 17629361. 
  177. de Roux, A; Schmöle-Thoma, B; Siber, GR; Hackell, JG; Kuhnke, A; Ahlers, N; Baker, SA; Razmpour, A; Emini, EA; Fernsten, PD; Gruber, WC; Lockhart, S; Burkhardt, O; Welte, T; Lode, HM (Apr 1, 2008). "Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.". Clinical Infectious Diseases. 46 (7): 1015–23. doi:10.1086/529142. PMID 18444818. 
  178. Jódar, L; Butler, J; Carlone, G; Dagan, R; Goldblatt, D; Käyhty, H; Klugman, K; Plikaytis, B; Siber, G; Kohberger, R; Chang, I; Cherian, T (Jul 4, 2003). "Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.". Vaccine. 21 (23): 3265–72. doi:10.1016/s0264-410x(03)00230-5. PMID 12804857. 
  179. Long, D, M. Skoberne, T. M. Gierahn, S. Larson, J. A. Price, V. C, A. E. Baccari, K P. Cohane, D. Garvie, G. R. Siber, and J. B. Flechtner,. Identification of novel virus-specific antigens by CD4+ and CD8+ T cells from asymptomatic HSV-2 seropositive and seronegative donors. Manuscript submitted, Virology 2014.

Books and other monographs

  1. Siber, GR (1980). "Antibiotics and Infectious Diseases". In John W. Graef; Thomas E. Cone. Manual of pediatric therapeutics. (2nd ed.). Boston: Little, Brown. pp. 331–391. ISBN 0316139114. Retrieved 7 April 2014. 
  2. Siber GR. The Immunocompromised Host: Passive Immunization In: The Immunocompromised Host. 1985; 2:2-12.
  3. Siber GR; Nydegger, U.E. (1986). "Heavy and light chain restriction of human antibodies to polysaccharide antigens". In Andreas Morell, U. E. Nydegger. Clinical use of intravenous immunoglobulins : proceedings of a conference held at Interlaken, Sept. 15-18, 1985 (1st ed.). London ; Orlando: Academic Press. pp. 47–54. ISBN 0125232829. Retrieved 7 April 2014. 
  4. Warren HS, Novitsky TJ, Martin P, Roslansky PF, and Siber GR. Endotoxin neutralizing capacity of sera from different patient populations assessed by the limulus lysate test. In: Watson SW, Levin J, Novitsky TJ, eds. 2nd International Conference on Endotoxins and their detection with the Limulus Amebocyte lysate test. Progress in Clinical and Biological Research. New York City: Alan R. Liss, Inc., 1987.
  5. Pelton SI, Teele DW, Reimer CB, de Lange GG, Siber GR, and the Boston Otitis Media Study Group. Immunologic characteristics of children with frequent recurrences of otitis media. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. Recent advances in otitis media with effusion. Proceedings of the Fourth International Symposium.
  6. Ambrosino DM, Morell A, Vassalli G, de Lange GG, Skvaril F and Siber GR. Correlations of G2m(n) and Km(1) allotypes with subclass and light chain specific antibody. In: Skvaril F, Morell A, eds. Clinical aspects of IgG subclasses and therapeutic applications. London: Academic Press, 1987.
  7. Siber GR, Ambrosino DM. Hyperimmune Human Immunoglobulins: Preparation and Characterization of H. influenzae b, Pneumococcal and Meningococcal globulin. In: Robbins JB, Schneerson R, Klein D, Sadoff J, Hardegree MC, eds. Bacterial Vaccines. New York: Praeger, 1987.
  8. Siber GR. Special Lecture: importance of IgG subclasses and genetic factors in predicting susceptibility to bacterial infections. In: Recent advances in otitis media. Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. BC Decker, Inc., 1988:135-140.
  9. Fischer GW, Siber GR. Human hyperimmune globulins for bacterial infections in high-risk children. In: Cryz SJ, eds. Vaccines and Immunotherapy. New York: Pergamon Press, 1991.
  10. Siber GR, Snydman DR. Use of immune globulins in the prevention and treatment of infections. In: Remington J, Swartz M, eds. Current Clinical Topics in Infectious Diseases. Volume 12. Boston: Blackwell Scientific Publications, 1992.
  11. Siber GR, Saladino RA, Kuppermann N, Nelson D, Garcia CT, Parsonnet J, Hammer B, Thompson C, Novitsky TJ, Fleischer GR. Effect of a recombinant endotoxin neutralizing protein from Limulus polyphemus on gram negative sepsis. In Levin J, ed. Proceedings of the 2nd Conference of the International Endotoxin Society, Vienna, Austria, August 1992. Amsterdam: Elsevier Science Publishers BV, 1992.
  12. Siber GR, Samore MH. Whooping Cough. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fanci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine 13th edition Baltimore:McGraw Hill, 1993;658-661.
  13. Gupta RK, Alonso MJ, Langer R, Siber GR. Development of a single dose tetanus toxoid based on controlled release from biodegradable and biocompatible polyester microspheres. In: Brown F, Chanock R, Ginsberg H, Lerner R, eds.Vaccines 93, (Cold Spring Harbor Laboratory, New York) 391-396;1993.
  14. Reid R, Siber GR, Thompson C, Hill J, Santosham M. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of haemophilus influenzae b and pneumococcal disease. In: Ellis RW, Granoff DM, eds. Development and Clinical Uses of Haemophilus b Vaccine. Marcel Dekker, New York, 1994;329-338.
  15. Gupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminum and calcium compounds. In: Powell MF and Newman MJ eds. Vaccine Design: The Subunit and Adjuvant Approach. Plenum Press, New York, 1995;229-248.
  16. Saladino RA, Siber GR, Thompson C, Novitsky TJ, Fleisher GR. Therapeutic potential of a recombinant endotoxin neutralizing protein from Limulus polyphemus. In: Morrison DC and Ryan JL eds. Novel Therapeutic Strategies in the Treatment of Sepsis. Marcel Dekker, New York, 1995.
  17. Saladino RA, Siber GR, Thompson C, Novitsky TJ, Fleisher GR (1996). "Therapeutic potential of a recombinant edotoxin neutralizing protein from Limulus polyphemus". In David C. Morrison, John L. Ryan. Novel therapeutic strategies in the treatment of sepsis. New York: M. Dekker. ISBN 9780824796617. Retrieved 7 April 2014. 
  18. Gupta RK, Griffin P, Chang A-C, Rivera R, Anderson R, Rost B, Cecchini D, Nicholson, Siber GR (1996). "The role of adjuvants and delivery systems in modulation of immune response to vaccines". In Sara Cohen; Avigdor Shafferman. Novel Strategies in Design and Production, held May 7-11, 1995, in Eliat, Israel]. New York: Plenum Press. pp. 49–52. ISBN 9780306452116. 
  19. Siber GR; Orenstein, Walter A.; Offit, Paul A. (2008). "Non-infectious Disease Vaccines". In Stanley A. Plotkin. Vaccines (5th ed.). Philadelphia, PA: Saunders/Elsevier. pp. 1275–1282. ISBN 9781416036111. Retrieved 7 April 2014. 
  20. George R. Siber; Keith P. Klugman; P. Helena Mäkelä, eds. (2008). Pneumococcal vaccines : the impact of conjugate vaccine. Washington, DC: ASM Press. ISBN 9781555814083. 

Letters

  1. Eshelman, Fred N.; Siber GR; Smith AL; Smith DH (June 1976). "Estimations of peak tissue concentrations of gentamicin". The Journal of Pediatrics. 88 (6): 1066–1067. doi:10.1016/S0022-3476(76)81089-X. PMID 1271182. 
  2. Kresel, JJ; Smith, AL; Siber, GR (Jun 1977). "Stability of gentamicin in plastic syringes.". American journal of hospital pharmacy. 34 (6): 570, 575. PMID 879174. 
  3. Ossowski, EM; Hostetter MK; Schwartz AL; Siber GR; Schiffman G (Aug 1986). "Pneumococcal vaccine failure.". American family physician. 34 (2): 175–7. PMID 3751833. 
  4. Ambrosino, DM; Siber GR; Chilmonczyk BA; Jernberg JA; Finberg RW (Sep 1987). "Impaired immune response to polysaccharides.". The New England Journal of Medicine. 317 (13): 837–9. doi:10.1056/nejm198709243171315. ISSN 0028-4793. PMID 3627203. 
  5. Cooperstock, M; Siber GR; Thompson C; Fleischer G (Sep 1992). "Detoxification of meningococcal endotoxin by polymyxin B.". The Journal of Infectious Diseases. 166 (3): 682–3. doi:10.1093/infdis/166.3.682. PMID 1500758. 
  6. Leszczynski, J; Gupta, CK; Siber, GR (Sep 1993). "The use of intravenous gamma globulin for CMV prophylaxis.". Transplantation. 56 (3): 765. doi:10.1097/00007890-199309000-00043. PMID 8212176. 
  7. Mulholland, E.K.; Hoestermann, A.; Suara, R.O.; Adegbola, R.A.; Siber, G.; Thompson, C.; Greenwood, B.M. (March 1994). "Haemophilus Influenzae type b meningitis after three doses of vaccine". The Lancet. 343 (8900): 794. doi:10.1016/S0140-6736(94)91870-8. 
  8. Gupta, RK; Siber, GR (Mar 1995). "Need for a reference preparation of pertussis antitoxin for Chinese hamster ovary cell assay.". Biologicals : journal of the International Association of Biological Standardization. 23 (1): 71–3. doi:10.1016/1045-1056(95)90015-2. PMID 7619440. 
  9. Gupta, RK; Siber, GR (Aug 1995). "Reappraisal of existing methods for potency testing of vaccines against tetanus and diphtheria.". Vaccine. 13 (11): 965–6. doi:10.1016/0264-410x(95)00027-x. PMID 8525688. 

Abstracts

  1. Echeverria PE, Siber GR, Smith DH, and Smith A.L. Age-dependent changes in gentamicin pharmacokinetics. l4th International Conference on Antimicrobial Agents and Chemotherapy. San Francisco, 1974.
  2. Weitzman SA, AisenbergAC, Siber GR, Stossel TP, and Smith DH.The treatment of Hodgkin's disease and humoral immunity. American Association for Cancer Research, 1976.
  3. Ward JI, Siber GR, Scheifele DW, and Smith D.H. Rapid diagnosis of H. influenzae type b infections by latex particles agglutination and counterimmunoelectrophoresis. Presented at the Society for Pediatric Research, San Francisco, 1977.
  4. Scheifele DW, Daum R, Syriopoulou V, Siber GR, and Smith AL.Comparison of antigen detection methods in a primate model of Hemophilus meningitis. Society for Pediatric Research, 1977 (San Francisco).
  5. Siber GR, Smith AL, and Levin MJ. High doses gentamicin for febrile granulocytopenia cancer patients. Interscience Conference on Antimicrobial Agents and Chemotherapy, (ICAAC), 1977. (Abstract #408).
  6. Siber GR, Levin MJ, Mayer R, and Frei E. Relationship of gastrointestinal permeability, granulocytopenia, and infections during 5-FU therapy. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1977 (Abstract #4ll).
  7. Siber GR, Gorham C, Durbin W, Lesko L, and Levin MJ. The pharmacology of IV trimethoprim-sulfamethoxazole in children and adults. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1979. (Abstract #1236).
  8. Ward JI, Clegg HW, Wasserman R, Rosenberg G. and Siber GR. Hemophilus influenzae pneumonia: A prospective study demonstrating the utility of latex agglutination for diagnosis. Pediatric Research 1981; 15:624. (Abstract #1088).
  9. Romagnoli M, Flynn K, Siber GR, and Goldmann D. Pharmacokinetics of moxalactam in children. Presented at 12th International Congress of Chemotherapy, Florence, Italy, July 19–24, 1981.
  10. Goorin AM, Hershey BJ, Gelber RD, Siber GR, Flynn K, Sallan S, and Levin MJ. Prophylactic use of Trimethoprim-Sulfamethoxazole (T-S) in children with acute lymphocyte leukemia (ALL). Pediatric Research, 1982 16:204A (Abstract #754).
  11. Ambrosino DM, Siber GR, van Loghem E, and Schiffman G.: Increased antibody response to immunization with Haemophilus influenzae type b (HIB) and pneumococcal capsular polysaccharide (PS) vaccines in adults with the G2m(n) allotype. Pediatric Research 1982, 16:234A. (Abstract #93l).
  12. Russell R, Mather F, Siber GR, Rosenberg G, and Daum R. Prognostic value of serial antigen quantitation in H. influenzae type B (HIB) meningitis. Pediatric Research 1982, 16:250A. (Abstract #1028).
  13. Schreiber JR, Ambrosino DM, Daum RS, and Siber GR. Prevention of H. influenzae type b (HIB) disease in infant rats with human hyperimmune globulin (HIG). Pediatric Research 1982 16:250A. (Abstract #1029).
  14. Ambrosino DM, Gorham CA, McIver J, and Siber GR. Pharmacokinetics of anti-polyribophosphate antibody in human hyperimmune globulin in children. Pediatric Research 1983;17:264A. (Abstract #1066).
  15. Ambrosino DM, Rosenberg GE, De Lange G and Siber GR. Association of the G2m(n) immunoglobulin allotype with H. influenzae type b disease Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1983. (Abstract #946).
  16. Schreiber J, Barrus V, and Siber GR. Comparison or Native and Reduced and Alkylated Human IV Immune Serum Globulin (ISG) in Experimental H. influenzae type b infection. Pediatric Research 1984, 18:285A (Abstract #1137).
  17. Ward JI, Ambrosino D, Burkhart K, Sonne B, Dengrove J, and Siber G. Passive protection for Haemophilus influenzae type b (Hib) Disease: Antibody levels in infants given hyperimmune globulin. Pediatric Research 1984, 18:237A. (Abstract #1151). Presented at Plenary Session.
  18. Schreiber J, Barrus V, Cates KL, and Siber GR. Role of isotype of human anticapsular antibody to H. influenzae b in vitro and in vivo Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1983 (Abstract #834).
  19. Ambrosino DM, Barrus VA, DeLange GM, and Siber GR. Association of the Km(1) immunoglobulin allotype with anti-PRP antibody response in Caucasians. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1984, (Abstract #835).
  20. Warren HS, Novitsky TJ, and Siber GR. Measurement of the endotoxin neutralizing capacity of human plasma. Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC) (Abstract #414).
  21. Wright DC, Sadoff JC, Futrovsky S, Kauffman B, Kania S, and Siber GR. Mouse human hybridomas secreting human immunoglobulin against pneumococcal polysaccharides. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1984 (Abstract #826).
  22. O'Rourke E, Martin P, Macone A, Anderson A, Goldmann D, Siber G, and Ambrosino D. Pneumococcal antigen detection in children at risk for occult bacteremia. Pediatric Research 1985 (Abstract).
  23. Wright D, Siber G, Kania S, Waters D, Werner B, and Sadoff J. Development of a human monoclonal antibody against cytomegalovirus. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1984 (Abstract #841).
  24. Shurin PA, Giebink GS, Siber GR, Ambrosino D, Overman M, Bauer T. Immunoglobulin G (IgG) in mucosal immunity: Prevention of experimental pneumococcal otitis media (OM) with human bacterial polysaccharide immunoglobulin (BPIG). Pediatric Research 1986; 20: p321A (Abstract #977).
  25. Schreiber JR, Basker CJ, Siber GR. High dose anticapsular IgG protects complement (C) depleted infant rats from infection with Haemophilus influenzae b (Hib). Pediatric Research 1986; 20: p320A (Abstract #973).
  26. Santosham, M, Reid R, Aspery K, Almeido J, Ambrosino D, Page P, Moxon R, and Siber G. Prevention of H. influenzae b (Hib) and pneumococcal infections in high-risk infants with bacterial polysaccharide immune globulin (BPIG). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1986 (Abstract #213).
  27. Letson GW, Santosham M, Reid R, Burns A, Jahnke D, Smith C, Johnson C, Siber G, Ambrosino D, and Moxon R. Immunogenicity and safety of Haemophilus influenzae b (Hib) diphtheria toxoid conjugate vaccine given with or without bacterial polysaccharide immune globulin (BPIG) in Navajo infants. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1986 (Abstract #214).
  28. Ambrosino DM, Umetsu DT, Geha RS, Michaels RS, Noyes J, Goularte TA, Howie G, and Siber GR. Impaired antibody response to polysaccharide antigen in children with recurrent sinopulmonary infections and normal IgG subclass concentrations. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1986
  29. Santosham M, Reid R, Aspery K, Almeido J, Ambrosino D, Page P, Moxon R and Siber G. Prevention of H. influenze b (Hib) and pneumococcal infections in high-risk infants with Bacterial Polysacharide Immune Globulin (BPIG). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1986. (Abstract #213).
  30. Letson GW, Santosham M, Reid R, Burns B, Jahnke A, Smioth D, Johnson C, Siber G, Ambrosino D and Moxon R. Immunogenicity and safety of Haemophilus influenzae b (Hib) diphtheria toxoid conjugate vaccine given with or without Bacterial Polysaccharide Immune Globulin (BPIG). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1986. (Abstract #214).
  31. Ambrosino DM, Umetsu DT, Geha RS, Michaels RS, Noyes J, Goularte TA, Howie G and Siber GR. Impaired antibody response to polysaccharide antigen in children with recurrent sinopulmonary infections and normal IgG subclass concentrations. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1986. (Abstract #860).
  32. Sood SK, Schreiber JR, Siber GR and Daum RS. Susceptibility to invasive H influenzae (Hi) infection immediately after immunization with the capsular vaccine. American Pediatric Society and Society for Pediatric Research Meetings, 1987. (Abstract #967).
  33. Schreiber JR, Basker C, Priehs C and Siber GR. Deleterious effect of immune globulin in the treatment of H. influenzae b infection in infant rats. American Pediatric Society and Society for Pediatric Research Meetings, 1987. (Abstract #961).
  34. Pollack HJ, Siber GR and Edelson PJ. Lack of response to Hemophilus influenzae b (Hib) polysaccharide vaccine in children with HIV infection. 1st International Conference on AIDS in Children, Adolescents and Heterosexual Adults, Atlanta, Georgia, February, 1987. (Abstract P20).
  35. Siber GR, Santosham M, Priehs CM, Reid R, Letson W, Madore D and Eby R. Impaired antibody (Ab) response to H. influenzae b (Hib) capsular polysaccharide (CP) in Native American children. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1987. (Abstract #326).
  36. Pelton SI, Siber GR, and Telle DW. Association between antibody to selected serotypes of S. pneumoniae and recurrent otitis media. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1987 (Abstract #1238).
  37. Thakrar H, Siber GR, Yancey BA, Todd CW, Cohen ND, Herzog LW, Bithoney WG, Roskey AM, Lowe CU, Schneerson R, Sekura RD and Robbins JB. Safety and immunogenicity of Pertussis Toxoid Vaccine in 18 month old children. Pediatric Research, 1988;23(4). Program Issue: APS-SPR (Abstract #1100).
  38. Siber G, Winberry L, Todd C, Samore M, Sentissi A and Cohen N. Safety and immunogenicity in adults of pertussis toxoid inactivated with tetranitromethane. International Woprkshop on Bordetella pertussis, Rocky Mountain Laboratories, Hamilton, Montana, August 18–20, 1988.
  39. Winberry L, Walker R, Cohen N, Todd C, Sentissi A and Siber G. Evaluation of a new method for inactivating pertussis toxin with tetranitromethane. International workshop of Bordetella pertussis, Rocky Mountain Laboratories, Hamilton, Montana, August 18–20, 1988.
  40. Rehmus J, Johnson C, Marchant C, Carlin S, Super D, Van Hare G, Siber G, Jones P and Shurin P. Bacterial Polysaccharide Immune Globulin prophylaxis of otitis media in high-risk infants. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1988 (Abstract #334).
  41. Guenter D, Siber G, Law B, Moffatt M. Antibody (Ab) to H. influenzae type b (Hib) capsular polysaccharide (prp) in Maternal (m) and cord (c) sera from Inuit (I), Indian (II) and Caucasian (C) populations in the NWT and Manitoba. 8th International Congress on Circumpolar Health.
  42. Baldwin G, Caputo G, Alpert G, Parsonett J, Siber G, Baskin M, Fleisher G. Polymyxin B for experimental shock from meningococcal endotoxin. Pediatric Research 1989;25(4) Program Issue APS-SPR (Abstract #184).
  43. Samore MH, Siber GR. Pertussis toxin increases susceptibility of infant rats to Haemophilus influenzae type b. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1989 (Abstract #345).
  44. Samore MH, Siber GR. Pertussis toxin increases to tal and antigen-specific IgG1 and IgE in Mice. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1989 (Abstract #445).
  45. Siber GR, Basker CJ, Insel R. Cross-reactive idiotype (Id) marker associated with high antibody (Ab) responses to H. influenzae b (Hib) polysaccharide (Ps) in Adults. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1989 (Abstract #449).
  46. Baldwin G, Alpert G, Caputo GL, Gillis Z, Parsonnet J, Siber G, Fleisher G. Polymyxin B moderates TNF levels and shock in E. coli but not N meningitidis endotoxemia. Pediatric Research. 1990;27(4) Program Issue APS-SPR (Abstract #151).
  47. Saladino R, Alpert G, Baldwin G, Caputo G, Parsonnet J, Gillis Z, Fleisher G, Siber G. Effect of intravenous immunoglobulin in a rabbit model of meningococcal endotoxic shock. Pediatric Research. 1990;27(4) Program Issue APS-SPR (Abstract #191).
  48. Alpert G, Baldwin G, Caputo GL, Wainwright N, Fleisher G, Parsonnet J, Siber GR. Endotoxin binding protein (EBP) protects rabbits from meningococcal endotoxic shock. Pediatric Research. 1990;27(4) Program Issue APS-SPR (Abstract #973).
  49. Noel GJ, Edelson PJ, Siber GR, Mosser DM. Complement (C') mediates antibody-dependent ingestion of H. influenzae type B (Hib) by macrophages (MACS). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1989 (Abstract #1052).
  50. Phipps DC, Strohmeyer S, Quataert SA, Siber G, Madore DV. Standardization of ELISA for the quantitation of antibodies to S. pneumoniae capsular polysaccharides (PNPS). Pediatric Research. 1990;27(4) Program Issue APS-SPR (Abstract #1058).
  51. Cryz SJ Jr, Siber GR, Cohen N, Winberry L, Todd C, Berger R, Just M. Safety and immunogenicity of a tetranitromethane pertussis toxoid in 14- to 18-month-old Swiss children. In: Manclark, Charles R. (ed.) 1990. Sixth international symposium on pertussis abstracts. Department of Health and Human Services, United States Public Health Service, Bethesda, Maryland. DHHS Publication No. (FDA) 90-1162. 260 pages (No. 96).
  52. Siber GR, Herzog L, Marchant CD, Cohen N, Winberry LW, Todd CW. Pertussis toxoid inactivated with tetranitromethane: safety and immunogenicity in adults, children, and infants. In: Manclark, Charles R. (ed.) 1990. Sixth international symposium on pertussis abstracts. Department of Health and Human Services, United States Public Health Service, Bethesda, Maryland. DHHS Publication No. (FDA) 90-1162. 260 pages (No. 82).
  53. Garcia CT, Saladino RA, Thompson C, Hammer B, Fleisher GR, Siber GR. Effect of endotoxin neutralizing protein (ENP) on gram negative sepsis in a rabbit model. Pediatric Research. 1991;29(4). Program Issue: APS-SPR. Abstract #1012.
  54. Saladino R, Garcia G, Thompson C, Hammer B, Siber G, Fleisher G. Assessment of intravenous endotoxin binding protein in a rabbit model. Pediatric Research. 1991;29(4). Program Issue APS-SPR. Abstract #182.
  55. Englund JA, Glezen WP, Turner C, Harvey J, Siber G. Maternal immunization with PRP and PRP-conjugate vaccines for passive protection of infants. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1991 (Abstract # 68).
  56. Steinhoff MC, Onyango F, Mbori-Ngacha D, Siber G. The effect of nutritional status on the antibody (Ab) response of Kenyan children to Haemophilus influenzae type b (Hib) conjugate vaccine. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 1991 (Abstract #70).
  57. Oyango F, Steinhoff MC, Mbori-Ngacha D, Siber G. Chronic childhood malnutrition reduces antibody response to H. influenzae type b (HIB)-protein conjugate vaccine. American Society of Tropical Medicine and Hygiene. 1991.
  58. Siber G, Nelson D, Kupperman N, Thompson C, Hammer B, Wainwright N, Novitsky T, Onderdonk A, Fleisher G. Recombinant endotoxin neutralizing protein from L. polyphemus reduces mortality of gram negative sepsis in rat models. Keystone Symposium on Recognition of Endotoxin in Biologic Systems. J Cellular Biochem. 1992.
  59. Drabick J, Bhattacharjee A, Williams W, Siber G, Cross A. Covalent polymyxin B-starch and polymyxin B-immunoglobulin G conjugates as novel anti-endotoxin reagents. American Federation for Clinical Research. 1992.
  60. Kuppermann N, Nelson D, Garcia CT, Saladino RA, Thompson CM, Hammer BK, Wainwright N, Novitsky TJ, Fleisher GR, Siber GR. Recombinant endotoxin neutralizing protein from L. polyphemus reduces mortality from E. coli sepsis in rat model. Pediatric Research 1992;31(4) Program Issue APS-SPR (Abstract # 176)
  61. Saladino R, Garcia C, Hammer B, Thompson C, Parsonnet J, Wainwright N, Novitsky T, Siber G, Fleisher G. Effect of an endotoxin neutralizing protein in an E. coli sepsis model in the rabbit. Pediatric Research 1992;31(4) Program Issue APS-SPR (Abstract #195)
  62. Saladino R, Erikson M, Levy N, Bachman D, Siber G, Fleisher G. Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children. Pediatric Research. 1992;31(4) Program Issue APS-SPR (Abstract #194)
  63. Santosham M, Reid GR, Almeido-Hill J, Thompson C, Wolff MC, Siber GR. Efficacy of bacterial polysaccharide immune globulin (BPIG) for prevention of bacteremic pneumococcal infections in Apache children. Pediatric Research. 1992;31(4) Program Issue APS-SPR (Abstract #1055)
  64. Alonso MJ, Cohen S, Park TW, Gupta RK, Siber GR, Langer R. Controlled release of tetanus toxoid from poly (lactic/glycolic acid) microspheres. Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 19 (1992)
  65. Saladino R Garcia C, Hammer B, Thompson C, Parsonnet J, Novitsky T, Onderdonk, Siber G, Fleischer G. Recombinant Endotoxin Neutralizing Protein Improves Survival in Rabbits with E. coli sepsis. Proceed. Inter. Endotoxin Society. 1992.
  66. Dushay KM, Thompson C, Remington L, Skornik W, Siber G, Rose R. Aerosol administration of bacterial polysaccharide immune globulin (BPIG) to mice. ALA/ATS International Conference, Sam Francisco, CA, May 1993 (abstract).
  67. Gupta RK, Siber GR. Neutralizing and IgG subclass antibody responses to aluminum phosphate, calcium phosphate, and stearyl tyrosine adsorbed tetanus toxoid. Modern Approaches to New Vaccines. Cold Spring Harbor, NY, September, 1992 (abstract).
  68. Marchant CD, Loughlin AM, Siber GR, Lett SM. Pertussis in Massachusetts, 1981-1991. 11th Meeting of The European Society for Paediatric Infectious Diseases, Helsinki, Finland, May 1993 (abstract).
  69. Siber GR, Prince A, Leombruno D, Gonin R, Walsh EE, Hemming VG, Anderson R, McIver J, Leszczynski J. Comparison of neutralizing and protective activity in cotton rats of respiratory syncytial virus (RSV) immune globulin (IG) and standard IV-IG. Pediatr Res 33:183A, 1993 (abstract #1081).
  70. Molrine DC, GuinanEC, Parsons SK, Weinstein HJ, Antin JH, Wheeler C, Siber GR, Schiffman G, Ambrosino DM. Polysaccharide-conjugate repsonses in bone marrow transplant patients. Pediatr Res 33:175A, 1993 (abstract #1033).
  71. Stack AM, Saladion RA, Thompson C, Sattler F, Weiner D, Parsonnet J, Nariuchi H, Siber GR, Fleisher GR. Murine anti-TNF monoclonal antibody reduces TNF levels in an E. coli sepsis model in the rabbit. Pediatr Res 33, 184A, 1993 (abstract #1089).
  72. Englund JA, Glezen WP, Siber GR, Anwaruddin R, Turner CS, Thompson C. PRP-antibody (Ab) in infants born to mothers immunized with PRP or PRP-conjugate vaccines during pregnancy. 33rd ICAAC, New Orleans, LA, October 1993.
  73. Bruss JA, Malley R, Parker JC, Morella S, Dhalla MN, McIver J, Fredeking T, Siber GR. Treatment of severe pertussis with intravenous pertussis immune globulin (P-IGIV). Latebreaker Session, 33rd ICAAC, New Orleans, LA, October 1993.
  74. Leombruno D, Coutts E, Troccoli NM, Leszczynski J, Siber GR. Concentration of respiratory syncytial virus (RSV) IgG-subclass specific antibodies in RSV immune globulin (RSV-IGIV) and conventional immune globulin (IGIV). 28th Annual Regional Meeting, Cambridge, MA, November 1993.
  75. Schwendeman SP, Gupta RK, Costantino HR, Siber GR, Langer R. Stability of tetanus vaccine for encapsulation in bioerodible polymer microspheres. Pharm Res 1993;10:S-220.
  76. Nelson DS, Kuppermann N, Saladino RA, Personnet J, Thompson DM, Hammer BK, Sattler F, Novitsky TJ, Fleisher GR, Siber GR. A randomized trial of a recombinant endotoxin neutralizing protein versus a monoclonal antibody to endotoxin for the treatment of E. coli sepsis in a rat model. Pediatric Res 33:177A, 1993 (abstract #1043).
  77. Williams WJ, Yuan L, Finkelman M, Siber GR, CRoss AS. Efficacy of endotoxin neturalizing protein in a mouse model of sepsis. Clinical Res. 1993.
  78. Nelson D, Kuppermann N, Saladino R, Parsonnet J, Thompson C, Hammer B, Sattler F. Novitsky TJ, Fleisher G, Siber G. A randomized trial of a recombinant endotoxin neutralizing protein versus a monoclonal antibody to endotoxin for the treatment of E. coli sepsis in a rat model. Pediatric Research. 1993;33:N1043, 177A.
  79. Gupta RK, Siber GR. Comparison of adjuvant activities of aluminum phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals 1994;22:53-63.
  80. Gupta R, Griffin P, Loes A, Mond J, Varanelli C, Wallach D, Cooper P, Alonso M, Langer R and Siber GR. Comparative evaluation of aluminum phosphate, calcium phosphate, stearyl tyrosine, γ inulin, conjugation to dextran, liposomes, poly lactide/glycolide microspheres as adjuvants/delivery systems for tetanus and diphtheria toxoids. Abstract presented at the 94th General Meeting of the American Society for Microbiology, May 23–27, 1994, Las Vegas.
  81. Schwendeman SP, Lee JH, Gupta RK, Costantino HR, Siber GR, Langer R. Inhibition of moisture-induced aggregation of tetanus toxoid by protecting thiol groups. Proceed Intern Symp Control Rel Bioact Mater 1994;21:54-55.
  82. Thorne GM, Dhalla M, Bruss J, Siber G. Application of polymerase chain reaction (PCR) to the detection of Bordetella pertussis in pediatric patients. 34th ICAAC, Orlando, Florida 1994.
  83. Dushay K, Brain J, Rees D, Donaghey T, Siber G, McIver J, Leombruno D, O’Donnell C. Anti-respiratory syncytial virus immunoglobulin administration via aerosol to normal human volunteers. American Thoracic Society, Seattle, Washington 1995.
  84. Troccoli NM, Higham S, Gupta CK, Ferren-Gardner C, Hemming V, Siber GR, McIver J. Intravenous immune globulin functional activities: assessment in high-titer hyperimmune globulins and following solvent-detergent viral inactivation. Conference of Viral Blood Safety and Screening, Washington DC, 1994.
  85. Roback M, Saladino R, Stack A, Schwarz HP, Siber G. Effect of activated protein c on endotoxin shock in rabbits. Pediatric Research, San Diego, CA 1994;37(4):52A.
  86. Staat MA, Deloria MA, Shadle C, Bohidar N, Mendelman PM, Santosham M, Micham S, Gupta RK, Kaslow RA, Siber GR. Simultaneous administration of Haemophilus influenzae type B conjugate vaccine (PRP-OMP) and diphtheria-tetanus-pertussis vaccine (DTP): the effect of PRP-OMP on the DTP immune response. Pediatric Research, San Diego, CA 1994;37(4):115A.
  87. DeVincenzo JP, Skornik WA, Murthy GGK, Brain JD, McIver J, Siber GR. Aerosol delivery of respiratory syncytial virus (RSV) antibody to the lungs of cotton rats. Pediatric Research, San Diego, CA 1994;37(4):173A.
  88. Kurt-Jones EA, Sattler FA, Novitsky T, Fleisher GR, Siber GR. Endotoxin neutralizing protein binds to cells and inhibits lipopoly. Pediatric Research, San Diego, CA 1994;37(4):181A.
  89. Stack A, Saladino R, Marra M, Novitsky T, Siber GR, Fleisher GR. A comparison of recombinant endotoxin neutralizing protein versus a recombinant bactericidal/permeability increasing protein variant for the treatment of E. Coli sepsis in the rat. Pediatric Research, San Diego, CA 1994;37(4):188A.
  90. DeVincenzo JP, Murthy GGK, Skornik, WA, Brain, JD, McIver J, Siber GR. Aerosolized respiratory syncytial virus (RSV) antibody delivered to the lungs of cotton rats. Infectious Diseases Society of America, San Francisco, CA, 1995.
  91. DeVincenzo JP, Skornik WA, Murthy GGK, Brain JD, McIver J, Siber GR. Aerosol delivery of respiratory syncytial virus (RSV) antibody to the lungs of cotton rats. San Diego, CA, abstract published in Pediatric Research, 1995 37(4):173A.
  92. Connor EM and the PREVENT Study Group. Reduction of respiratory syncytial virus-associated hospitalization in children with premature birth and/or bronchopulmonary dysplasia using monthly infusion of RSV immune globulin (RespiGam, RSV-IGIV). SPR, 1996.
  93. Alonso JM, Villamayor B, Tobio M, Schwendeman S, Gupta RK, Siber GR, Langer R. Innovative approaches for the stabilization and controlled release of tetanus vaccine from polyester microspheres. Proceed Intern Symp Control Rel Bioact Mater 1996;23.
  94. Siber GR. Immunotherapy of respiratory syncytial virus infections (RSV). Vereniging voor Infectieziekten (Infectious Diseases Society of the Netherlands and Flanders). Ned Tijdsch Geneesk 1995;139:1954-55.
  95. Gupta RK, Siber GR. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. IABS, Bergen, Norway, 1996.
  96. Gupta RK, Rivera GP, Siber GR. Development of an animal model to assess the immunogenicity of a single-dose tetanus vaccine based on controlled release from biodegradable polymer microspheres. IABS, Bergen, Norway, 1996.
  97. DeVincenzo JP, Montana JB, Murthy GGK, Skornik WA, Brain JD,McIver J, Siber GR. Aerosolized respiratory syncytial virus (RSV) antibody treatment of RSV infected cotton rats. IDSA, San Francisco, CA 1996.
  98. Kurt-Jones EA, Thompson C, Novitsky T, Siber G, Fleisher G. Endotoxin neutralizing protein inhibits the response of human peripheral blood mononuclear cells to LPS and non-LPS stimuli. ICAAC, 1996.
  99. DeVincenzo JP, Montana JB, Murthy GGK, Skornik WA, Brain JD, McIver J, Siber GR. Aerosolized respiratory syncytial virus (RSV) antibody treatment of RSV infected cotton rats. 36th ICAAC, New Orleans, LA, September, 1996 (Abstract # 101).
  100. Black S, Shinefield H, Ray P, Fireman B, Austrian, R, Siber G, Hackell J, Kohberger R, Chang I. Efficacy of Heptavalent Conjugate Pneumococal Vaccine (Wyeth Lederle) in 37,000 infants and children: Impact on Pneumonia, otitis media and an update on invasive disease-results of the Northern California Kaiser Permanente Efficacy Trial. ICAAC, San Francisco, September, 1999 (Abstract #1398).
  101. Siber G. Vaccine-type and non-vaccine type pneumococci after administration of 9valent CRM 197 conjugate pneumococcal vaccine (Pnc CRM9). Second International Symposium on Pneumococci and Pneumococcal Diseases, Sun City, South Africa, 19–23 March 2000.
  102. Dagan R, Givon-Lavi M, Kikuler-Cohen O, Zamir D, Fraser R, Kohberger R, Siber G. Anti-capsular IgG (PS-IgG) concentration correlate with nasopharyngeal (NP) acquisition of vaccine serotypes (VT) Pneumococci (Pnc) in toddlers during a 2-year follow up (F/U). ICAAC, 2001.
  103. deRoux A, Schmoele-Thoma B, Ahlers N, Gruber W, Siber G, Sikkema D, Welte T, Lode H. Different immune response after sequential use of pneumococcal polysaccharide and pneumococcal conjugate vaccine. 8th Annual Conference on Vaccine Research, Baltimore, Md, 9-11, May, 2005.
  104. Siber G. A manufacturer’s perspective on increasing costs of Vaccine Development. AIDS Vaccine Conference, Montreal, 06-09, September, 2005.
  105. deRoux A, Kuhnke A, Schmoele-Thoma B, Ahlers N, Siber G, Gruber W, Lockhart S. Fernsten P, Baker S, Schmidt-Ioanas M. Welte T, Lode H. Immunogenicity, safety and tolerability of a sever valent pneumococcal conjugate (7vPnc) and pneumococcal polysaccharide (23vPS) vaccine booster dose 12 months after first injection in elderly individuals. IDSA, San Francisco, 06-09, October, 2005.
  106. deRoux A, Schmole-Thoma B, Ahlers N, Baker S, Fernsten P, Razmpour A, Siber G, Gruber W, Lockhart S, Welte T, Lode H. Differing functional antibody responses after sequential use of pneumococcal polysaccharide ad pneumococcal conjugate vaccine. ISPPD5, Alice Springs, Central Australia, April 2–6, 2006.
  107. Hackell J, Paradiso PR, Siber G. Public health potential of a 23vPnC vaccine for immunization of adults in the US. ISPPD5, Alice Springs, Central Australia. April 2–6, 2006.
  108. deRoux A, Schmole-Thoma B, Schmidt-Ioanas M, Kuhnke A, Ahlers N. Baker S, Razmpour A, Siber G, Gruber W, Lockhart S. Fernsten P, Welte T, Lode H. Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly. ISPPD5, Alice Springs, Central Australia. April 2–6, 2006.
  109. Scott DA, Komjathy SF, Ruckel J, Supan L, Dar M, Baker S, Razmpour A, Hu B, Fernsten P, Lockhart S, Gruber W, Siber G. Safety and immunogenicity of the 13-valent pneumococcal conjugate vaccine in healthy adults. ISPPD5, Alice Springs, Central Australia. April 2–6, 2006.
  110. Schmole-Thoma B, Ahlers N, Siber G, Laudat F, Baker S, Fernsten P, Razmpour A, Lockhart S, Gruber W. Opsonophagocytic responses to pneumococcal conjugate vaccine in the elderly. ISPPD5, Alice Springs, Central Australia, April 2–6, 2006.
This article is issued from Wikipedia - version of the 11/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.